NCT00564772View on ClinicalTrials.gov

Raltegravir Kaletra Pharmacokinetics

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Healthy
Interventions
DRUG

Raltegravir, lopinavir, ritonavir

4 days of raltegravir, then 10 days of Kaletra, then 4 days of both with 12 PK sampling at the end of each period.

Trial Locations (1)

55114

Prism Research Inc, Saint Paul

All Listed Sponsors
lead

Allina Health System

OTHER

NCT00564772 - Raltegravir Kaletra Pharmacokinetics | Biotech Hunter | Biotech Hunter